☰

Patricia Sue Grigson

Affiliations: 
Pennsylvania State University College of Medicine, Hershey, PA, United States 
Area:
Behavioral Neuroscience
Google:
"Patricia Grigson"
Mean distance: 14.55 (cluster 19)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Charles F. Flaherty grad student Rutgers, New Brunswick
Ralph Norgren post-doc Penn State

Children

Sign in to add trainee
Jennifer Elaine Nyland grad student Penn State College of Medicine
Christopher B. Jenney grad student 2010- Penn State College of Medicine
Elizabeth M. Colechio grad student 2011- Penn State College of Medicine
Robert A. Wheeler grad student 2003 Penn State
Robert C. Twining grad student 2000-2007 Penn State College of Medicine
Christopher S. Freet grad student 2010 Penn State
Rastafa I. Geddes grad student 2010 Penn State
Matthew D. Puhl grad student 2006-2010 Penn State
Megan Morse grad student 2012 Penn State
Caesar G. Imperio grad student 2010-2015 Penn State College of Medicine
Anne E. Baldwin post-doc 2001-2006 Penn State College of Medicine

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McFalls AJ, Jenney C, Stanford RS, et al. (2022) Greater avoidance of a saccharin cue paired with passive delivery of heroin is associated with a select increase in expression of CRFR2 and CRFbp in the hippocampus in rats. Brain Research Bulletin. 191: 48-60
McFalls AJ, Imperio CG, Woodward E, et al. (2022) An RNA-seq study of the mPFC of rats with different addiction phenotypes. Brain Research Bulletin. 191: 107-120
Evans B, Stoltzfus B, Acharya N, et al. (2022) Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats. Brain Research Bulletin
Urbanik LA, Acharya NK, Grigson PS. (2022) Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats. Brain Research Bulletin. 189: 155-162
Yingst JM, Lester C, Livelsberger C, et al. (2022) Pilot randomized controlled trial evaluating the effect of random nicotine delivery on cigarettes per day and smoke exposure. Brain Research Bulletin. 188: 30-37
Douton JE, Acharya NK, Stoltzfus B, et al. (2022) Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats. Behavioural Pharmacology
Douton JE, Horvath N, Mills-Huffnagle S, et al. (2021) Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats. Addiction Biology. e13117
Nyland JE, Raja-Khan NT, Bettermann K, et al. (2021) Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study. Diabetes
Douton JE, Norgren R, Grigson PS. (2020) Effects of a glucagon-like peptide-1 analog on appetitive and consummatory behavior for rewarding and aversive gustatory stimuli in rats. Physiology & Behavior. 229: 113279
Douton JE, Augusto C, Stoltzfus B, et al. (2020) Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats. Behavioural Pharmacology
See more...